ARCHIVES

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators

May 3, 1974

Cancer Control Planning Conference Delayed To 1977

August 13, 1976

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011